SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-08-007724
Filing Date
2008-03-26
Accepted
2008-03-26 16:09:46
Documents
4
Period of Report
2008-03-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS INC 8-K 3-20-2008 form8k.htm 8-K 44938
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 169801
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 164861
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 97402
  Complete submission text file 0001140361-08-007724.txt   478683
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50590 | Film No.: 08712257
SIC: 2834 Pharmaceutical Preparations